Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing Type
4
Filing Date
3/2/2025
Updated
3/3/25, 2:32 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership